Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2

1(33.3%)

Phase 1

1(33.3%)

Phase 4

1(33.3%)

3Total

Phase 2(1)

Phase 1(1)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT03516266Unknown

A Cross-sectional Study of Female Pelvic Floor Muscle Function in Chinese Healthy Female

Role: collaborator

NCT03506204Unknown

The Pelvic Floor Muscle Function in Chinese Primipara, a One-year Cohort Study

Role: collaborator

NCT03518918Unknown

Establishing the Diagnosis Standard and Analysis the Risk Factors of POI in Chinese Women

Role: collaborator

NCT02980250Phase 4Completed

Multi-Center Study of Different Doses Domperidone in Feeding Intolerance

Role: collaborator

NCT01503801Phase 2Completed

Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia

Role: collaborator

NCT01533350Completed

Receptivity Assessment of Homogeneous Endometrium in Late Follicle Phase

Role: lead

NCT00730496Phase 1Completed

Injection of Day 2 Embryo Culture Supernatant Into the Uterine Cavity Didn't Improve Implantation and Pregnancy Rates

Role: lead

NCT00643708Completed

Ovarian Laser Treatment in Women With Polycystic Ovarian Syndrome: A Randomized Study on the Laser Dose

Role: lead

All 8 trials loaded